−0.30SEK
−49.73 MSEK
50.90 MSEK
70.67 M
About ENZYMATICA AB
Sector
Industry
CEO
Claus Egstrand
Website
Headquarters
Lund
Employees (FY)
18
Founded
2007
ISIN
SE0003943620
FIGI
BBG001Y25Z66
Enzymatica AB engages in the research, development, and sale of medical technology products. It offers medical devices in upper respiratory infections and oral health. The company was founded by Ulf Blom, Jorgen Rexo, Ake Larsson, and Staffan Bergqvist in 2007 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ENZY is 3.39 SEK — it has increased by 0.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ENZYMATICA AB stocks are traded under the ticker ENZY.
ENZYMATICA AB is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
ENZY stock is 8.72% volatile and has beta coefficient of 0.62. Check out the list of the most volatile stocks — is ENZYMATICA AB there?
One year price forecast for ENZYMATICA AB has a max estimate of 6.00 SEK and a min estimate of 6.00 SEK.
ENZY earnings for the last quarter are −0.01 SEK per share, whereas the estimation was −0.04 SEK resulting in a 75.00% surprise. The estimated earnings for the next quarter are 0.13 SEK per share. See more details about ENZYMATICA AB earnings.
ENZYMATICA AB revenue for the last quarter amounts to 13.30 M SEK despite the estimated figure of 18.30 M SEK. In the next quarter revenue is expected to reach 18.20 M SEK.
Yes, you can track ENZYMATICA AB financials in yearly and quarterly reports right on TradingView.
ENZY stock has fallen by 7.38% compared to the previous week, the month change is a 2.73% rise, over the last year ENZYMATICA AB has showed a 43.64% increase.
ENZY net income for the last quarter is −14.06 M SEK, while the quarter before that showed −9.24 M SEK of net income which accounts for −52.24% change. Track more ENZYMATICA AB financial stats to get the full picture.
Today ENZYMATICA AB has the market capitalization of 586.03 M, it has increased by 18.75% over the last week.
No, ENZY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENZY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENZYMATICA AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 18.00 employees. See our rating of the largest employees — is ENZYMATICA AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENZYMATICA AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENZYMATICA AB stock shows the sell signal. See more of ENZYMATICA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ENZYMATICA AB future price: according to them, ENZY price has a max estimate of 6.00 SEK and a min estimate of 6.00 SEK. Read a more detailed ENZYMATICA AB forecast: see what analysts think of ENZYMATICA AB and suggest that you do with its stocks.